This bill allows for the prescription, distribution, and marketing of crystalline polymorph psilocybin upon its rescheduling by the FDA.

This bill amends Iowa law to permit the prescription, distribution, and marketing of crystalline polymorph psilocybin, also known as COMP 360, once it is rescheduled by the United States Food and Drug Administration (FDA). Currently, psilocybin is classified as a Schedule I substance in Iowa, with penalties for possession ranging from a serious misdemeanor to a class "B" felony. The bill specifies that upon FDA approval, the drug will be removed from Schedule I and rescheduled based on FDA recommendations and its listing in the federal Controlled Substances Act.

This bill allows for the prescription, distribution, and marketing of crystalline polymorph psilocybin upon its rescheduling by the FDA.

This bill amends Iowa law to permit the prescription, distribution, and marketing of crystalline polymorph psilocybin, also known as COMP 360, once it is rescheduled by the United States Food and Drug Administration (FDA). Currently, psilocybin is classified as a Schedule I substance in Iowa, with penalties for possession ranging from a serious misdemeanor to a class "B" felony. The bill specifies that upon FDA approval, the drug will be removed from Schedule I and rescheduled based on FDA recommendations and its listing in the federal Controlled Substances Act.